No Data
No Data
Shenzhen Changhong Technology: 2024 Interim Performance Forecast
Shenzhen Changhong Technology (SZSE:300151) Is Reinvesting At Lower Rates Of Return
Shenzhen Changhong Technology (300151.SZ): Some of the products under development have entered the small-scale product verification phase in mainstream wafer factories.
On June 17th, Gelonhui reported that Shenzhen Changhong Technology (300151.SZ) stated on the investor interaction platform that multiple products in the company's research have entered mainstream wafer fabs in China for validation, with some products entering the small-scale product validation stage in mainstream wafer fabs. The company is intensively training personnel and systems to prepare for mass production of products. Shenzhen Changhong Technology will continue to leverage its advantages in precision injection mold design and manufacturing technology at Dinglong and research and development advantages in semiconductor consumables to increase research and development of semiconductor carriers and clean packaging materials, actively expand related customer areas, and accelerate Shenzhen Changhong Technology's exploration pace in the semiconductor field.
Shenzhen Changhong Technology (300151.SZ): The controlling shareholder Li Huanchang completed a shareholding of 631,400 shares.
On June 17th, GeLongHui reported that Shenzhen Changhong Technology (stock code 300151.SZ) has received a notice from its controlling shareholder and actual controller, Mr. Li Huanchang, regarding the completion of the shareholding plan. According to the notice, the above shareholding plan has been fully implemented. Mr. Li Huanchang has cumulatively increased his shareholding in the company by 631,400 shares, accounting for 0.1186% of the total share capital, with a total increase of RMB 10.034335 million. The shareholding plan has been fully implemented.
Shenzhen Changhong Technology (stock code 300151.SZ): Zhejiang Baimingsheng and Fresenius Medical Care sign a strategic cooperation framework agreement.
Changhong Technology (300151.SZ) announced on June 5 that its subsidiary, Zhejiang Baiming Sheng Medical Technology Co., Ltd. ("Zhejiang Baiming Sheng"), and Fresenius Medical Care Deutschland GmbH (Fresenius Medical Care) signed a strategic cooperation framework agreement on June 4, 2024. The company has been working with Fresenius Medical Care since 2020, and the cooperation areas include high-polymer medical consumables products such as blood dialysis medical consumables and medical device components. The revenue amounts of the past three years account for the company's medical business.
Optimism for Shenzhen Changhong Technology (SZSE:300151) Has Grown This Past Week, Despite Five-year Decline in Earnings
No Data